INS and polycystic ovary syndrome: Particularly, a recent meta-analysis of nine RCTs involving 247 PCOS subjects and 249 controls demonstrated that 12–24 weeks of MI treatment resulted in significant decreases in fasting insulin levels and the homeostasis model assessment (HOMA) index, and a trend toward a reduced testosterone concentration [149].